Screener
InMed Pharmaceuticals INM Q1 2025 earnings
Reported May 12, 2025 · Before market open
Revenue$1.8M
EPS-$1.94
Next report
Sep 23, 2026 (In 5 days)Revenue estimate$2.1B
EPS estimate-$94.44
Versus estimates
Diluted EPS
FAQ
- When did InMed Pharmaceuticals report Q1 2025 earnings?
- InMed Pharmaceuticals (INM) reported Q1 2025 earnings on May 12, 2025 before market open.
- What were InMed Pharmaceuticals's Q1 2025 revenue and EPS?
- InMed Pharmaceuticals reported revenue of $1.8M and eps of $-1.94 for Q1 2025.
- How did InMed Pharmaceuticals's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 108.1% from $863.5K a year earlier and eps grew 46.1% from $-3.60.
- Where can I find InMed Pharmaceuticals's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001213900-25-042251) and the 10-Q periodic report (0001213900-25-042126) directly on SEC EDGAR. The filing index links above go to sec.gov.
